Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements - Summary of Reconciliation of Statements of Cash Flows (Detail)

v3.21.1
Restatement of Previously Issued Financial Statements - Summary of Reconciliation of Statements of Cash Flows (Detail) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Cash Flows from Operating Activities:        
Net income (loss)     $ (321,102) $ 4,595,625
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Gain on marketable securities, dividends and interest held in Trust Account $ 14,168 $ (1,760,594) (1,114,579) (1,760,594)
Loss on revaluation of warrant liability 6,936,250 (3,617,500) 1,172,500 (3,617,500)
General and administrative expenses paid by related party       2,206
Gain on revaluation of warrant liability 6,936,250 (3,617,500) 1,172,500 (3,617,500)
Changes in operating assets and liabilities:        
Prepaid expenses     (20,595) (138,629)
Accounts payable     (60,517)  
Accrued expenses     16,140 82,575
Net cash used in operating activities     (328,153) (836,317)
Cash Flows from Investing Activities:        
Cash deposited in Trust Account       (287,500,000)
Net cash used in investing activities       (287,500,000)
Cash Flows from Financing Activities:        
Proceeds from note payable to related party       250,000
Repayment of note payable and advances from related party       (252,206)
Proceeds received from initial public offering       287,500,000
Proceeds from private placement       7,750,000
Offering costs paid       (5,151,990)
Net cash provided by financing activities       290,095,804
Net change in cash     (328,153) 1,759,487
Cash - beginning of period     1,589,795 25,000
Cash - end of period 1,261,642 1,784,487 1,261,642 1,784,487
Supplemental disclosure of noncash activities:        
Offering costs included in accrued expenses       85,000
Offering costs included in accounts payable       2,600
Remeasurement of ordinary shares subject to possible redemption       26,789,590
Deferred underwriting commissions       9,187,500
As Reported        
Cash Flows from Operating Activities:        
Net income (loss)     851,398 1,626,364
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Gain on marketable securities, dividends and interest held in Trust Account 14,168 (1,760,594) (1,114,579) (1,760,594)
General and administrative expenses paid by related party       2,206
Changes in operating assets and liabilities:        
Prepaid expenses     (20,595) (138,629)
Accounts payable     (60,517)  
Accrued expenses     16,140 82,575
Net cash used in operating activities     (328,153) (188,078)
Cash Flows from Investing Activities:        
Cash deposited in Trust Account       (287,500,000)
Net cash used in investing activities       (287,500,000)
Cash Flows from Financing Activities:        
Proceeds from note payable to related party       250,000
Repayment of note payable and advances from related party       (252,206)
Proceeds received from initial public offering       287,500,000
Proceeds from private placement       7,750,000
Offering costs paid       (5,800,229)
Net cash provided by financing activities       289,447,565
Net change in cash     (328,153) 1,759,487
Cash - beginning of period     1,589,795 25,000
Cash - end of period 1,261,642 1,784,487 1,261,642 1,784,487
Supplemental disclosure of noncash activities:        
Offering costs included in accrued expenses       85,000
Offering costs included in accounts payable       2,600
Remeasurement of ordinary shares subject to possible redemption     851,400 276,823,340
Restatement Adjustment        
Cash Flows from Operating Activities:        
Net income (loss)     (1,172,500) 2,969,261
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Loss on revaluation of warrant liability     1,172,500  
Gain on revaluation of warrant liability $ 6,936,250 $ (3,617,500) 1,172,500 (3,617,500)
Changes in operating assets and liabilities:        
Net cash used in operating activities       (648,239)
Cash Flows from Financing Activities:        
Offering costs paid       648,239
Net cash provided by financing activities       648,239
Supplemental disclosure of noncash activities:        
Remeasurement of ordinary shares subject to possible redemption     $ (851,400) (250,033,750)
Deferred underwriting commissions       $ 9,187,500